MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1 | |
Sun, Y.; Cao, F-L; Qu, L-L; Wang, Z-M; Liu, X-Y | |
刊名 | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
![]() |
2019 | |
卷号 | 23期号:4页码:1459-1467 |
关键词 | MEG3 Liver cancer Cell proliferation Cell invasion AP1G1 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4547846 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Qilu Hosp, Dept Med Oncol, Qingdao, Peoples R China. 2.Shandong Univ, Qilu Hosp, De |
推荐引用方式 GB/T 7714 | Sun, Y.,Cao, F-L,Qu, L-L,et al. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,2019,23(4):1459-1467. |
APA | Sun, Y.,Cao, F-L,Qu, L-L,Wang, Z-M,&Liu, X-Y.(2019).MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,23(4),1459-1467. |
MLA | Sun, Y.,et al."MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 23.4(2019):1459-1467. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论